Introduction
============

*Stenotrophomonas maltophilia* (*S. maltophilia*) is a non-fermentative Gram-negative bacillus, previously known as *Pseudomonas maltophilia* and later *Xanthomonas maltophilia*. This bacterium is found in several environments such as water, soil, plants, food and hospital settings \[[@B1],[@B2]\]. It is increasingly recognised as a significant cause of hospital acquired infection particularly among severely debilitated and immunosuppressed patients, those receiving long-term antimicrobial therapy and those with indwelling central venous catheters. The resultant infections are extensive, with the respiratory tract, soft tissues and the skin most frequently involved \[[@B1]\]-\[[@B4]\]. Although the pathogen is considered to be an infrequent cause of meningitis, it has become a focus of interest not only due to increasing recognition of its pathogenic potential but also because of its marked antibiotic resistance \[[@B1]\].

Here we report a case of *S. maltophilia* meningitis in a baby boy after a neurosurgical procedure, successfully treated with the combination of trimethoprim-sulfamethoxazole and ciprofloxacin.

Case presentation
=================

A baby boy was delivered at 26 weeks of gestation after a spontaneous rupture of membranes. The patient was admitted to our neonatal intensive care unit with Apgar scores of two and eight at 1 and 5 minutes, respectively. On the 12th day of his life clinical and radiological signs of perforated necrotizing enterocolitis (NEC) occurred and required surgical intestinal resection. Cerebral ultrasound at day 15 of his life was performed and showed intraventricular haemorrhage and dilated cerebral ventricles. Because of NEC, temporary external cerebrospinal fluid (CSF) drainage was inserted. Two weeks after external CSF drainage was performed, he developed *Klebsiella BLEE* meningitis. Antibiotic therapy with meropenem was started and the external CSF drainage was replaced. After 19 days of treatment with meropenem a new CSF sample from drainage revealed 1200 cells/mm^3^ (95% neutrophils), protein 3.4 g/L and glucose 0.03 g/L. Gram-negative bacillus were seen on gram strain in the CSF culture and it was positive for *S. maltophilia*. The strain was only susceptible in vitro to trimethoprim-sulfamethoxazole (TMP-SMX), with a mean inhibitory concentration (MIC) of ≤2/38, minocycline and ciprofloxacin. TMP-SMX intravenous therapy (50 mg/kg per day in two divided doses) was commenced. The external ventricular drainage was not removed at this stage because the patient\'s state was critical. The next sample analysis of CSF from the drainage 14 days after starting TMP-SMX revealed the following profile: white blood cell count of 1300 cells/mm^3^ (90% neutrophils), protein 1.39 g/L and glucose 0.04 g/L. The CSF culture was still positive for *S. maltophilia* and consequently ciprofloxacin (15 mg/kg per day in two divided doses) was added to TMP-SMX. Furthermore, the external ventricular drainage was removed and after 7 days of therapy with ciprofloxacin in combination with TMP-SMX, the analysis of the CSF was normal and the culture was sterile. Finally, 21 more days of therapy were completed with both antibiotics. No adverse effects were found during ciprofloxacin treatment. There was no displacement of bilirubin with the use of sulfamethoxazole in our patient and the values were normal (maximum total bilirubin 1.27 mg/dL). A ventricular-peritoneal shunt was inserted after the infection was eradicated due to severe ventricular dilatation.

Discussion
==========

*S. maltophilia* is an extremely rare cause of meningitis and, to our knowledge, only 15 cases, including our case, have been reported to date \[[@B2]\]. Four cases were children including two neonates with *S. maltophilia* meningitis. The median age for the two female and two male infants was 5.3 months; range from 4 days to 13 months \[[@B2]\]-\[[@B5]\]. The two previous patients with neonatal *S. maltophilia* meningitis were preterm infants and were 4 and 7 days old, respectively. One patient died immediately after presentation and the other one was successfully treated with ciprofloxacin because of multi-resistant *S. maltophilia* (Table [1](#T1){ref-type="table"}).

###### 

Details of children with meningitis caused by *S. maltophilia*

  Case No   Reference/Year   Age/sex             Neurosurgical procedure   Therapy                         Outcome
  --------- ---------------- ------------------- ------------------------- ------------------------------- -----------
  1         \(1\) 1977       8 months/male       None                      Ampicilin, colistin             Died
  2         \(1\) 1977       13 months/ female   None                      Chloramphenicol, sulphadoxine   Recovered
  3         \(2\) 1984       7 days/male         None                      None                            Died
  4         \(3\) 2002       4 days/female       None                      Ciprofloxacin                   Recovered
  5         Present report   69 days/male        External (CSF) drainage   TMP-SMX, ciprofloxacin          Recovered

The reported risk factors associated with *S. maltophilia* infection are prematurity, neurosurgical procedures (especially shunts and drainages), intracranial haemorrhages and malignancies \[[@B6]\]. Our patient had undergone several neurosurgical procedures and also, importantly, had been treated with a previous broad-spectrum antibiotic such as carbapenem, which is also a suggested risk factor for infection with *S. maltophilia*\[[@B1],[@B6]\].

*S. maltophilia* is increasingly recognised as a cause of nosocomial infections of special interest because of its intrinsic resistance to multiple antimicrobial agents used to treat Gram-negative infections. It is resistant to a variety of antibiotics, for example aminoglycosides, ß-lactam agents and it is intrinsically resistant to carbapenems. Based on susceptibility studies, TMP-SMX is the drug of choice for treatment of *S. maltophilia* infections. However, recent data indicate that the percentage of strains resistant to TMP-SMX may be increasing \[[@B1],[@B3],[@B7],[@B8]\]. In this patient the pathogen was susceptible to this antimicrobial therapy but CSF cultures only became sterile after removal of the external ventricular drainage and the addition of ciprofloxacin to TMP-SMX. We decided to add ciprofloxacin because TMP-SMX is bacteriostatic and the infant was seriously ill. The administration of sulfamethoxazole, which binds to albumin and competes with bilirubin, can increase the possibility of hyperbilirubinaemia and serious neurological complications such as kernicterus in neonates. This was not observed in our patient.

With respect to ciprofloxacin, the optimal dose and duration of the treatment for neonatal Gram-negative meningitis remains uncertain. Lo et al. reported a preterm infant with multi-resistant *S. maltophilia* (including resistance to TMP-SMX) meningitis successfully treated with ciprofloxacin \[[@B3]\]. Due to the small number of cases and the short follow-up periods, further studies are needed to establish dosage, CSF ciprofloxacin concentrations and duration of treatment for meningitis. There is also very little information available on this drug sequelae \[[@B3],[@B7],[@B8]\]. The severe ventricular dilatation in our patient was due to intraventricular haemorrhage and the hearing deficit noted could be a consequence of meningitis. Long-term follow-up, including routine neurologic examination as well as visual and auditory evoked potentials, is obligatory. Our patient is the first case of *S. maltophilia* meningitis in a preterm infant successfully treated with the antimicrobial combination of TMP-SMX and ciprofloxacin.

Conclusions
===========

Due to the increase in meningitis caused by *S. maltophilia* in neurosurgical cases, and its marked resistance to antibiotics normally used to treat Gram-negative nosocomial infections, it should be considered as a potential cause of meningitis in patients with external ventricular drainage and long-term broad-spectrum antimicrobial therapy.
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